USE OF THE CA 125 ALGORITHM FOR THE EARLY DETECTION OF OVARIAN CANCER IN LOW RISK WOMEN
MD Anderson Study Status
The goal of this clinical research study is to evaluate a method involving a blood test, called CA-125, that may be helpful in the early detection of ovarian cancer in women who are at low risk.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Gynecologic Oncology & Reproductive Medicine
For general questions about clinical trials:
Due to our response to COVID-19, all blood donations at MD Anderson
Blood Donor Center locations are being held by appointment only.